These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15713681

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L, Tanaka M, Wait R, Shi YE, Brew K, Nagase H.
    Biochemistry; 2002 Dec 17; 41(50):15025-35. PubMed ID: 12475252
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).
    Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, D'Souza SE.
    J Biol Chem; 2006 Feb 10; 281(6):3157-64. PubMed ID: 16332693
    [Abstract] [Full Text] [Related]

  • 25. Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects.
    Duan JX, Rapti M, Tsigkou A, Lee MH.
    PLoS One; 2015 Feb 10; 10(8):e0136384. PubMed ID: 26308720
    [Abstract] [Full Text] [Related]

  • 26. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 27. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K.
    Protein Sci; 2007 Sep 01; 16(9):1905-13. PubMed ID: 17660250
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
    Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi I, Milla ME.
    J Biol Chem; 2004 Jul 23; 279(30):31638-45. PubMed ID: 15100227
    [Abstract] [Full Text] [Related]

  • 29. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G.
    Biochemistry; 1994 Mar 01; 33(8):2089-95. PubMed ID: 8117665
    [Abstract] [Full Text] [Related]

  • 30. Catalytic properties of ADAM12 and its domain deletion mutants.
    Jacobsen J, Visse R, Sørensen HP, Enghild JJ, Brew K, Wewer UM, Nagase H.
    Biochemistry; 2008 Jan 15; 47(2):537-47. PubMed ID: 18081311
    [Abstract] [Full Text] [Related]

  • 31. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.
    Li YY, McTiernan CF, Feldman AM.
    Cardiovasc Res; 1999 Apr 15; 42(1):162-72. PubMed ID: 10435007
    [Abstract] [Full Text] [Related]

  • 32. Tissue inhibitors of metalloproteinases: evolution, structure and function.
    Brew K, Dinakarpandian D, Nagase H.
    Biochim Biophys Acta; 2000 Mar 07; 1477(1-2):267-83. PubMed ID: 10708863
    [Abstract] [Full Text] [Related]

  • 33. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.
    Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S, Sloane BF, Fridman R, Kim HR.
    Cancer Res; 2005 Feb 01; 65(3):898-906. PubMed ID: 15705888
    [Abstract] [Full Text] [Related]

  • 34. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 35. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail.
    Murphy G, Knäuper V, Lee MH, Amour A, Worley JR, Hutton M, Atkinson S, Rapti M, Williamson R.
    Biochem Soc Symp; 2003 Jun 15; (70):65-80. PubMed ID: 14587283
    [Abstract] [Full Text] [Related]

  • 36. Engineering of selective TIMPs.
    Nagase H, Meng Q, Malinovskii V, Huang W, Chung L, Bode W, Maskos K, Brew K.
    Ann N Y Acad Sci; 1999 Jun 30; 878():1-11. PubMed ID: 10415716
    [Abstract] [Full Text] [Related]

  • 37. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY, Loss G, Carmody I, Cohen AJ.
    Transplantation; 2006 Dec 15; 82(11):1518-23. PubMed ID: 17164725
    [Abstract] [Full Text] [Related]

  • 38. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.
    Wang WM, Ge G, Lim NH, Nagase H, Greenspan DS.
    Biochem J; 2006 Sep 15; 398(3):515-9. PubMed ID: 16771712
    [Abstract] [Full Text] [Related]

  • 39. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
    Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM, Welgus HG.
    J Biol Chem; 1994 Apr 29; 269(17):12692-7. PubMed ID: 8175679
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).
    Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y.
    FEBS Lett; 2001 Apr 13; 494(3):192-5. PubMed ID: 11311239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.